Main description:

Newly updated with the latest information on inflammatory bowel disease, Curbside Consultation in IBD: 49 Clinical Questions, Third Edition contains brief, practical, and evidence-based answers to the most frequently asked questions that are posed during a "curbside consultation" between surgical colleagues.

Drs. David T. Rubin, Sonia Friedman, and Francis A. Farraye are joined by an expert group of contributors, offering advice, preferences, and opinions on tough clinical questions commonly associated with IBD. With a unique Q&A format, this text provides quick access to current information. Numerous images, diagrams, and references are included to better illustrate IBD.

Some of the questions answered inside the Third Edition include:

What are the new approaches to using and minimizing steroids?
What is the evolving role of calcineurin inhibitors in IBD?
Where should anti-IL-23 therapy be placed in the therapeutic algorithm for Crohn's disease and ulcerative colitis?
What should the clinicians and patients know about biosimilars?
What are JAK inhibitors? And when should they be used in IBD?
What is the approach to loss of response to biological therapy?
How should we screen our patients with IBD for depression and anxiety?

With information basic enough for trainees and expert practical advice that even high-volume clinicians will appreciate, Curbside Consultation in IBD: 49 Clinical Questions, Third Edition is a must-have. Gastroenterologists, surgeons, IBD nurses and advanced practice providers, and medical and surgical trainees at all levels will benefit from the user-friendly format and up-to-date advice for complicated cases.

Contents:

Dedication
About the Editors
Contributing Authors
Preface
Introduction
Section I Diagnosis and Prognosis
Question 1 How Can We Assess Prognosis in Crohn's Disease?
Carolina Palmela, MD and Joana Torres, MD, PhD
Question 2 How Do You Evaluate and Treat Mid- Proximal Small Bowel Crohn's Disease?
Jean A. Donet, MD and Mark Lazarev, MD
Question 3 What Is Your First- Line Approach to the Diagnosis and Treatment of Patients With Perianal Crohn's Disease?
Baldeep S. Pabla, MD, MSCI and David A. Schwartz, MD
Question 4 What Is the Updated Role of Capsule Endoscopy in IBD?
Shabana F. Pasha, MD and Jonathan A. Leighton, MD
Question 5 How Should We Be Using Fecal Markers in Our Patients?
Anthony Buisson, MD, PhD and David T. Rubin, MD
Question 6 What Endpoints Should We Aim for in IBD Medical Therapy?
Maia Kayal, MD and Jean-Frederic Colombel, MD
Section II Medical Treatment
Question 7 When Should We Be Using 5- Aminosalicylic Acids in IBD? How Do You Optimize Their Use?
Stephen B. Hanauer, MD and Madeline Bertha, MD
Question 8 What Is Ste roid Dependence and How Is It Managed?
David B. Sachar, MD
Question 9 What Are the New Approaches to Using and Minimizing Ste roids?
Irving Levine, MD and Brian P. Bosworth, MD
Question 10 Should You Use Concomitant Immunomodulators With Biological Therapies in IBD?
Remo Panaccione, MD
Question 11 If, When, and How Should Thiopurines Be Used in IBD?
Jennie Clough, MBBS and Peter M. Irving, MBBS, MA, MD
Question 12 How Should Methotrexate Be Used in IBD?
Hans Herfarth, MD, PhD and Edward L. Barnes, MD, MPH
Question 13 What Is the Evolving Role of Calcineurin Inhibitors in IBD?
Ralley Prentice, MBBS and Britt Christensen, BSc, MBBS (Hons), MPH, PhD
Question 14 What Preparations Should Occur Before Initiating Biologic Therapy?
Akriti P. Saxena, MD and Mark T. Osterman, MD, MSCE
Question 15 Where Should Anti- Integrin Therapy Be Placed in the Therapeutic Algorithm for Crohn's Disease and Ulcerative Colitis?
Rachel W. Winter, MD, MPH and Sonia Friedman, MD
Question 16 Where Should Anti-Interleukin 23 Therapy Be Placed in the Therapeutic Algorithm for Crohn's Disease and Ulcerative Colitis?
Joel Pekow, MD
Question 17 What Should Clinicians and Patients Know About Biosimilars?
Ferdinando D'Amico, MD, PhD and Silvio Danese, MD, PhD
Question 18 What Are Janus Kinase Inhibitors and When Should They Be Used in IBD?
Roni Weisshof, MD and David T. Rubin, MD
Question 19 What Is the Approach for Loss of Response to Biological Therapy?
Konstantinos Papamichael, MD, PhD and Adam Cheifetz, MD
Question 20 How Should Proactive Therapeutic Drug Monitoring Be Considered in Our Patients?
Joseph D. Feuerstein, MD and William T. Clarke, MD, MSc
Question 21 What Are the Risks of Biologic Therapies and How Do You Communicate Them to Patients?
Susan Connor, MBBS (Hons 1), B Med Sci, PhD and Yang (Clare) Wu, MBChB
Question 22 When Should We Consider Deescalation of Therapy?
Seth R. Shaffer, MD, MS and David T. Rubin, MD
Question 23 Can You Restart a Biological Therapy After a Drug Holiday? How Do You Do This?
Filip J. Baert, MD, PhD and David Drobne, MD, PhD
Question 24 How Can I Get My Patients With IBD the Therapy They Need?
Shivani A. Patel, PharmD, BCPS and Toni M. Zahorian, PharmD, BCACP
Section III Alternative Treatments
Question 25 What Is the Role of Probiotics for Patients With IBD?
Kerri Glassner, DO and Bincy P. Abraham, MD, MS
Question 26 What Do I Tell My Patient With IBD Who Is Asking About Cannabis as Therapy?
Jami Kinnucan, MD and Arun Swaminath, MD
Section IV Special Populations
Question 27 How Do You Treat Pouchitis and What Do You Do for Recurrent or Refractory Pouchitis?
Iris Dotan, MD and Idan Goren, MD
Question 28 My Patient With IBD Is Complaining of Joint Pain. What Should I Do?
Abha G. Singh, MD and Arthur Kavanaugh, MD
Question 29 What Are the Diagnostic and Therapeutic Approaches to the Patient With IBD With Pain?
Emily Weaver, LCSW and Eva Szigethy, MD, PhD
Question 30 My Patient on Tumor Necrosis Factor Alpha Therapy Has a Rash. What Should I Do?
Oluwakemi Onajin, MD and Diana Bolotin, MD, PhD
Question 31 What Is the Approach to Primary Sclerosing Cholangitis in IBD?
Bilal Hameed, MD and Norah Terrault, MD, MPH
Question 32 What Is the Best Medical Therapy for IBD in Older Patients?
Seymour Katz, MD
Question 33 How Should Clinicians Treat Men With IBD? What Are the Unique Concerns?
Aoibhlinn O'Toole, MD and Sonia Friedman, MD
Question 34 What Is the Updated Approach to IBD Medical Therapy in Pregnancy and What Is Known About Neonatal Outcomes in Babies Born
to Mothers With IBD?
Muhammad Bader Hammami, MD and Uma Mahadevan, MD
Section V Infection and Malignancy Prevention
Question 35 How Do You Handle a Patient With IBD With Clostridioides difficile Infection?
Alexander N. Levy, MD and Jessica R. Allegretti, MD, MPH
Question 36 How Do You Treat IBD in the Setting of Current or Previous Cancer?
Steven H. Itzkowitz, MD and Jordan E. Axelrad, MD, MPH
Question 37 What Is the Updated Approach to Surveillance and Colorectal Cancer Prevention in IBD?
Jimmy K. Limdi, MBBS and Francis A. Farraye, MD, MSc
Section VI Surgical Treatment
Question 38 What Is the Appropriate Evaluation of the Preoperative Patient With IBD? (Malnutrition, Steroids, Smoking)
Amy L. Lightner, MD
Question 39 My Patient With Crohn's Disease Has an Ileal Abscess. What Is the Appropriate Management and Timing of Medical and Surgical Therapies?
Victor G. Chedid, MD, MSc and Sunanda V. Kane, MD, MSPH
Question 40 What Is the Updated Approach to Monitoring and Prevention in a Patient With Crohn's Disease After an Ileocecectomy and Primary Anastomosis?
Ashwin N. Ananthakrishnan, MD, MPH
Question 41 How Does Perioperative Immune Suppression Affect Surgical Outcomes in IBD?
Shintaro Akiyama, MD, PhD; Akihiro Yamada, MD, PhD; and
Atsushi Sakuraba, MD, PhD
Question 42 Does the Type of Surgical Anastomosis (End- to- End Versus Side- to- Side) Make a Difference in Long- Term Crohn's Disease Outcomes and in Recurrence?
Jana G. Hashash, MD, MSc; Andrew R. Watson, MD, MLitt; and
David G. Binion, MD
Section VII Health Maintenance
Question 43 What Is the Most Successful Strategy to Promote Smoking Cessation in Patients With Crohn's Disease?
Michael Buie, BHSc and Gilaad G. Kaplan, MD, MPH
Question 44 Which Vaccines Should Patients With IBD Receive?
Freddy Caldera, DO, MS and Francis A. Farraye, MD, MSc
Question 45 How Can Gastroenterologists Address IBD-Related Health Maintenance in Clinical Practice?
Erica R. Cohen, MD and Gil Y. Melmed, MD, MS
Question 46 How Should We Screen Our Patients With IBD for Depression and Anxiety?
Alyse Bedell, PhD and Laurie Keefer, PhD
Question 47 What Is the Role of Diet in the Treatment of IBD and How Do I Discuss This With My Patients?
James D. Lewis, MD, MSCE and Tamar Pfeffer Gik, RD, MSc
Question 48 What Advice Should I Give the Patient With IBD Who Is Traveling?
Kay Greveson, BA, MSc and Shomron Ben- Horin, MD
Question 49 How Should We Approach the Diagnosis and Evaluation of Sexual Dysfunction in Patients With IBD?
Punyanganie S. de Silva, MBBS, MPH and Sonia Friedman, MD
Financial Disclosures
Index